Top Markets
Coin of the day
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Zhejiang AngLiKang Pharmaceutical CO.,LTD.

002940
Rank in Stocks #11260
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on... Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies, with a particular emphasis on oral cephalosporin antibiotics, as well as treatments for cardiovascular, renal (kidney), and central nervous system diseases. The company was established in 2001 and maintains its headquarters in Shengzhou, China.
Share Price
$3.69
Last synced: 2026-08-28
Market Cap
$722.97M
Change (1 day)
-1.62%
Change (1 year)
-46.81%
Country
CN
Trade Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)

Category

Number of shares outstanding for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)
Number of shares outstanding as of August 2026: 0
According to Zhejiang AngLiKang Pharmaceutical CO.,LTD. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors